Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 195.88M | 199.34M | 326.49M | 511.57M | 446.85M | 213.12M |
Gross Profit | 5.12M | 4.57M | 3.99M | 18.87M | 8.86M | 16.03M |
EBITDA | -7.87M | 10.07M | 15.82M | 16.44M | 15.84M | -9.87M |
Net Income | 1.81M | 2.42M | 810.00K | 2.96M | 652.00K | -25.75M |
Balance Sheet | ||||||
Total Assets | 237.39M | 224.08M | 214.17M | 222.79M | 201.97M | 185.79M |
Cash, Cash Equivalents and Short-Term Investments | 8.04M | 3.87M | 17.22M | 11.88M | 7.03M | 7.36M |
Total Debt | 37.39M | 5.17M | 2.15M | 3.39M | 35.86M | 45.72M |
Total Liabilities | 149.21M | 136.00M | 128.51M | 142.00M | 124.14M | 108.61M |
Stockholders Equity | 88.18M | 88.08M | 85.66M | 80.79M | 77.83M | 77.18M |
Cash Flow | ||||||
Free Cash Flow | 14.21M | -8.89M | 3.50M | 31.13M | 13.90M | -24.25M |
Operating Cash Flow | 16.64M | -4.27M | 11.66M | 41.21M | 28.75M | -11.69M |
Investing Cash Flow | -1.64M | -3.49M | -7.74M | -9.39M | -14.76M | -11.79M |
Financing Cash Flow | -12.08M | -5.59M | 1.42M | -25.90M | -13.89M | 7.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $60.53B | 6.18 | 14.62% | 4.96% | 1.21% | 2.15% | |
72 Outperform | HK$8.39B | 20.61 | 6.48% | 11.76% | -22.77% | -53.94% | |
58 Neutral | HK$14.15B | 4.41 | -3.01% | 7.30% | 3.67% | -54.16% | |
53 Neutral | HK$148.80M | 124.44 | 1.19% | ― | -34.92% | ― | |
46 Neutral | €4.12B | ― | -29.17% | 16.77% | -11.94% | -756.32% | |
44 Neutral | HK$179.08M | ― | ― | -15.39% | 19.69% | ||
40 Underperform | €172.38M | ― | -238.71% | ― | -43.46% | 31.62% |